Genescience Pharmaceuticals Co., Ltd.

Number of R&D People: 42

1. Our company' s new drug, Genfulin™, Molgramostim Gel, a topical gel indicated for the treatment of wound healing, is expected to get approval by China' s SFDA in early 2007.

2. Per ourselves capacity of R & D, our product of pegylated Somatropin has successfully entered phrase Ⅲ this year.

3. We are still developing the new products in relation to the hepatitis and oncology.